HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Xin Yu Selected Research

Dexamethasone (Maxidex)

1/2021Pomalidomide, bortezomib, and dexamethasone for multiple myeloma previously treated with lenalidomide (OPTIMISMM): outcomes by prior treatment at first relapse.
1/2020Health-related quality-of-life results from the phase 3 OPTIMISMM study: pomalidomide, bortezomib, and low-dose dexamethasone versus bortezomib and low-dose dexamethasone in relapsed or refractory multiple myeloma.
1/2019Cereblon gene expression and correlation with clinical outcomes in patients with relapsed/refractory multiple myeloma treated with pomalidomide: an analysis of STRATUS.
1/2019Pomalidomide, bortezomib, and dexamethasone for patients with relapsed or refractory multiple myeloma previously treated with lenalidomide (OPTIMISMM): a randomised, open-label, phase 3 trial.
9/2017Adverse event management in patients with relapsed and refractory multiple myeloma taking pomalidomide plus low-dose dexamethasone: A pooled analysis.
12/2016Pomalidomide plus low-dose dexamethasone in patients with relapsed/refractory multiple myeloma and moderate renal impairment: a pooled analysis of three clinical trials.
1/2016Analysis of renal impairment in MM-003, a phase III study of pomalidomide + low - dose dexamethasone versus high - dose dexamethasone in refractory or relapsed and refractory multiple myeloma.
10/2015Impact of prior treatment and depth of response on survival in MM-003, a randomized phase 3 study comparing pomalidomide plus low-dose dexamethasone versus high-dose dexamethasone in relapsed/refractory multiple myeloma.
10/2015Cytogenetics and long-term survival of patients with refractory or relapsed and refractory multiple myeloma treated with pomalidomide and low-dose dexamethasone.
9/2015Pomalidomide and Low-Dose Dexamethasone Improves Health-Related Quality of Life and Prolongs Time to Worsening in Relapsed/Refractory Patients With Multiple Myeloma Enrolled in the MM-003 Randomized Phase III Trial.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Xin Yu Research Topics

Disease

187Neoplasms (Cancer)
05/2024 - 06/2007
53Schizophrenia (Dementia Praecox)
03/2024 - 09/2004
30Hepatocellular Carcinoma (Hepatoma)
11/2023 - 07/2008
29Infections
01/2024 - 12/2012
27Alzheimer Disease (Alzheimer's Disease)
12/2023 - 11/2003
25Neoplasm Metastasis (Metastasis)
03/2024 - 09/2013
21Cognitive Dysfunction
03/2023 - 06/2010
20Major Depressive Disorder (Major Depressive Disorders)
10/2023 - 01/2010
18Breast Neoplasms (Breast Cancer)
03/2024 - 03/2002
18Inflammation (Inflammations)
10/2023 - 08/2008
16Multiple Myeloma
10/2022 - 10/2013
15Carcinogenesis
05/2024 - 09/2012
15Wounds and Injuries (Trauma)
09/2022 - 07/2010
14Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung)
05/2024 - 01/2021
14Parkinson Disease (Parkinson's Disease)
06/2023 - 01/2012
12COVID-19
05/2024 - 01/2020
12Lung Neoplasms (Lung Cancer)
05/2024 - 10/2015
12Pain (Aches)
01/2024 - 09/2013
12Stroke (Strokes)
11/2023 - 08/2003
11Stomach Neoplasms (Stomach Cancer)
11/2023 - 10/2015
11Neurodegenerative Diseases (Neurodegenerative Disease)
09/2023 - 02/2012
10Bipolar Disorder (Manic Depressive Psychosis)
05/2024 - 04/2016
10Body Weight (Weight, Body)
01/2023 - 06/2013
10Melanoma (Melanoma, Malignant)
12/2022 - 01/2017
9Carcinoma (Carcinomatosis)
05/2024 - 10/2010
9Lymphoma (Lymphomas)
04/2024 - 12/2008
9Fibrosis (Cirrhosis)
02/2024 - 10/2009
9Mental Disorders (Mental Disorder)
06/2023 - 01/2015
9Colorectal Neoplasms (Colorectal Cancer)
01/2022 - 10/2015
8Hemorrhage
02/2024 - 04/2014
8Rectal Neoplasms (Rectal Cancer)
06/2018 - 01/2015
7Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
04/2024 - 12/2008
7Disease Progression
03/2024 - 01/2013
7Obesity
06/2023 - 01/2012
7Hypoxia (Hypoxemia)
01/2022 - 08/2003
6Pancreatic Neoplasms (Pancreatic Cancer)
06/2023 - 01/2017
6Dementia (Dementias)
01/2023 - 11/2005
6Glioblastoma (Glioblastoma Multiforme)
01/2023 - 08/2014
5Atherosclerosis
04/2024 - 09/2011
5Sepsis (Septicemia)
03/2024 - 09/2019
5Tuberculosis (Tuberculoses)
01/2024 - 10/2016
5Rheumatoid Arthritis
01/2024 - 07/2010
5Fatigue
01/2024 - 01/2013
5Nausea
01/2024 - 09/2013
5Vomiting
11/2023 - 09/2013

Drug/Important Bio-Agent (IBA)

54Proteins (Proteins, Gene)FDA Link
05/2024 - 03/2002
44Biomarkers (Surrogate Marker)IBA
05/2024 - 12/2010
41MicroRNAs (MicroRNA)IBA
10/2023 - 07/2013
28Antipsychotic Agents (Antipsychotics)IBA
03/2024 - 12/2011
25Long Noncoding RNAIBA
04/2024 - 10/2015
21Messenger RNA (mRNA)IBA
05/2024 - 08/2003
20RNA (Ribonucleic Acid)IBA
05/2024 - 10/2002
18CytokinesIBA
12/2023 - 05/2010
16DNA (Deoxyribonucleic Acid)IBA
04/2024 - 08/2009
14Anti-Bacterial Agents (Antibiotics)IBA
01/2024 - 02/2013
13Antidepressive Agents (Antidepressants)IBA
01/2024 - 01/2010
13Dexamethasone (Maxidex)FDA LinkGeneric
01/2021 - 10/2013
13pomalidomideIBA
01/2021 - 10/2013
12Immune Checkpoint InhibitorsIBA
04/2024 - 01/2019
11Peptides (Polypeptides)IBA
03/2024 - 07/2008
10Small Interfering RNA (siRNA)IBA
01/2022 - 09/2012
9ZincIBA
01/2023 - 05/2015
9EnzymesIBA
01/2022 - 09/2008
9Neuroprotective AgentsIBA
01/2021 - 03/2008
8Risperidone (Risperdal Consta)FDA LinkGeneric
06/2023 - 12/2011
8Therapeutic UsesIBA
12/2022 - 10/2012
8Contrast MediaIBA
06/2022 - 08/2003
8Apolipoproteins E (ApoE)IBA
03/2022 - 06/2010
8Bortezomib (Velcade)FDA Link
01/2021 - 10/2013
8Lenalidomide (CC 5013)FDA Link
01/2021 - 10/2013
7Circular RNAIBA
02/2024 - 01/2020
7Glucose (Dextrose)FDA LinkGeneric
01/2024 - 07/2012
7Hormones (Hormone)IBA
12/2023 - 01/2012
7Olanzapine (Zyprexa)FDA Link
06/2023 - 01/2017
7AntigensIBA
06/2023 - 07/2008
7AntibodiesIBA
03/2023 - 08/2003
6Transcription Factors (Transcription Factor)IBA
05/2024 - 10/2002
6LigandsIBA
03/2024 - 10/2002
6Adenosine Triphosphate (ATP)IBA
12/2023 - 10/2006
6ErbB Receptors (EGF Receptor)IBA
07/2023 - 01/2019
6Lactic Acid (Lactate)FDA LinkGeneric
01/2023 - 10/2006
6Amyloid (Amyloid Fibrils)IBA
01/2022 - 08/2014
6CalciumIBA
01/2022 - 08/2003
6Brain-Derived Neurotrophic Factor (BDNF)IBA
10/2020 - 01/2010
6Amisulpride (Solian)IBA
06/2020 - 10/2015
5Protein Kinases (Protein Kinase)IBA
04/2024 - 01/2006
5pinitolIBA
03/2024 - 01/2021
5Blood Glucose (Blood Sugar)IBA
02/2024 - 01/2018
5CollagenIBA
01/2024 - 01/2018
5Indicators and Reagents (Reagents)IBA
12/2023 - 08/2019

Therapy/Procedure

97Therapeutics
05/2024 - 06/2007
26Drug Therapy (Chemotherapy)
03/2024 - 12/2010
24Immunotherapy
04/2024 - 07/2008
10Length of Stay
02/2024 - 04/2014
9Neoadjuvant Therapy
06/2023 - 11/2015
7Radiotherapy
06/2018 - 07/2007
6Precision Medicine
04/2024 - 08/2015
6Hepatectomy
06/2023 - 09/2013
5Operative Time
02/2024 - 11/2011
5Lasers (Laser)
01/2024 - 05/2010